Nutronis Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Agartala, Tripura, India, established in 2019.

2019 Agartala, Tripura, India Active

Last Updated: December 25, 2025

About Nutronis Lifesciences Private Limited

Nutronis Lifesciences Private Limited, a active private limited company, was established on 10 July 2019 in Agartala, Tripura, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24110TR2019PTC013681. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shyamal Kumar Podder (Director), Priyankar Roy (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Joynagar, Middle Road, Agartala, Tripura, 799001.

Company Details

CIN/LLPIN
U24110TR2019PTC013681
Registration Number
013681
Incorporation Date
10 July 2019
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Guwahati
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 25-12-2025
Paid Up Capital ₹ 0.10 M as on 25-12-2025
Company Age 6 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 26.79% (FY 2022)
Profit Growth **** 11.43% (FY 2022)
Ebitda **** 8.95% (FY 2022)
Net Worth 3.23% (FY 2022)
Total Assets **** 160.41% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Nutronis Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nutronis Lifesciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Shyamal Kumar Podder	Director	10 Jul 2019	Current
Priyankar Roy	Director	10 Jul 2019	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nutronis Lifesciences.

Nutronis Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.79% increase. The company also saw a substantial improvement in profitability, with a 11.43% increase in profit. The company's net worth moved up by a moderate rise of 3.23%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

26.79%

*******

Revenue from Operations

*******

26.79%

*******

Total Assets

*******

160.41%

*******

Profit or Loss

*******

11.43%

*******

Net Worth

*******

3.23%

*******

EBITDA

*******

8.95%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nutronis Lifesciences?

Unlock access to Nutronis Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nutronis Lifesciences?

Unlock and access historical data on people associated with Nutronis Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nutronis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutronis Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nutronis Lifesciences

Recent Activity within the Organization

Annual General Meeting

The activity Nutronis Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Nutronis Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati. was recorded as a recent event.
31 Mar 2025
Director Appointment

Shyamal Kumar Podder was appointed as a Director was appointed as a Director on 10 Jul 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
10 Jul 2019
Director Appointment

Priyankar Roy was appointed as a Director was appointed as a Director on 10 Jul 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
10 Jul 2019
Company Incorporation

Nutronis Lifesciences Private Limited was registered on 10 Jul 2019 with Roc Guwahati & aged 6 years 7 months as per MCA records. was recorded as a recent event.
10 Jul 2019

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Nutronis Lifesciences Private Limited?

The CIN of Nutronis Lifesciences Private Limited is U24110TR2019PTC013681.

Where is Nutronis Lifesciences Private Limited headquartered?

Nutronis Lifesciences Private Limited is headquartered at Joynagar, Middle Road, Agartala, Tripura, 799001.

When was Nutronis Lifesciences Private Limited incorporated?

Nutronis Lifesciences Private Limited was incorporated on 10 July 2019.

Who are the current directors of Nutronis Lifesciences Private Limited?

The current directors of Nutronis Lifesciences Private Limited are

What is the primary industry of Nutronis Lifesciences Private Limited?

The primary industry of Nutronis Lifesciences Private Limited is Pharma.

Is Nutronis Lifesciences Private Limited a listed company?

Nutronis Lifesciences Private Limited is unlisted.

What is the capital structure of Nutronis Lifesciences Private Limited?

The authorized capital of Nutronis Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available